Table 4.
Peptide aldehdye and boronic acid inhibitors of PSA.
| Compound | Ki(μM) | |
|---|---|---|
| Leucine aldehydes | ||
| 25 | Z-SSKLL-H | 6.51 ± 0.25 |
| 26 | Z-SSKFL-H | 11.9 ± 0.9 |
| 27 | Z-SSKYL-H | 13.09 ± 0.91 |
| 28 | Z-SSKML-H | 13.7 ± 1.2 |
| 29 | Z-SSKQL-H | 21.79 ± 0.51 |
| 30 | Z-SSKIL-H | 37.43 ± 2.43 |
| 31 | Z-SSKKL-H | 57.85 ± 1.14 |
| 32 | Z-SSKVL-H | 70.71 ± 1.77 |
| 33 | Z-SSKTL-H | >100 |
| 34 | Z-SSKAL-H | >100 |
| 35 | Z-SSKF(Br)L-H | >500 |
| 36 | Z-SSKLD-H | >1000 |
| 37 | Z-SKLL-H | 42.43 ± 2.13 |
| 38 | Z-SSKL-H | >1000 |
| 39 | Z-KLL-H | >100 |
| 40 | Z-YL-H | >500 |
| 41 | Z-KL-H | >1000 |
| 42 | Z-QL-H | >1000 |
| 43 | Z-SSKLL-H | >1000 |
| Norleucine aldehdyes | ||
| 44 | Z-SSKLNle-H | 11.24 ± 0.26 |
| 45 | Z-KLNle-H | 414.1 ± 22.49 |
| 46 | Z-KNle-H | >1000 |
| 47 | Z-QNle-H | >1000 |
| 48 | Z-SSKNle-H | >1000 |
| 49 | Z-SSKLNle-H | >1000 |
| Peptidyl boronic acids | ||
| 50 | Z-Q(boro)L | 265.15 ± 18.39 |
| 51 | Z-K(boro)L | 353.5 ± 23.68 |
| 52 | Z-SSK(boro)L | 18.49 ± 1.48 |
| 53 | Z-SSK(boro)Nle | 34.21 ± 0.83 |
| 54 | Z-KL(boro)L | 5.98 ± 0.24 |
| 55 | Z-KL(boro)NLe | 23.57 ± 0.47 |
| 56 | Z-SSKL(boro)Nle | 0.398 ± 0.020 |
| 57 | Z-SSKL(boro)L | 0.065 ± 0.005 |
| D-isomer amino acids | ||
| 58 | Z-SSKL(boro)L | 0.149 ± 0.009 |
| 59 | Z-SSKL(boro)L | 21.48 ± 2.28 |
| 60 | Z-SSKL(boro)L | 28.67 ± 1.32 |
| 61 | Z-SSKL(boro)L | 75.76 ± 5.21 |
| 62 | Z-SSKL(boro)L | 32.21 ± 1.73 |
| 63 | Z-SSKL(boro)L | 227.27 ± 11.61 |
| 64 | Z-SSKL(boro)L | 439.94 ± 19.04 |
| Lysine derivatives | ||
| 65 | Z-SSL(boro)L | 3.86 ± 0.29 |
| 66 | Z-SSK(Ac)L(boro)L | 0.294 ± 0.026 |
Residues containing D-isomer amino acids are underlined.